Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Telavancin hydrochloride
Drug ID BADD_D02144
Description Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. MRSA is an important pathogen capable of causing hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and skin and subcutaneous tissue infections among others.
Indications and Usage For the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria like methicillin-susceptible or -resistant Staphylococcus aureus, vancomycin-susceptible Enterococcus faecalis, and Streptococcus pyogenes, Streptococcus agalactiae, or Streptococcus anginosus group. Also for the treatment of adult patients with hospital-acquired bacterial pneumonia (HAP) and ventilator-associated bacterial pneumonia (VAP), known or suspected to be caused by susceptible isolates of Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant S. aureus).
Marketing Status approved
ATC Code J01XA03
DrugBank ID DB06402
KEGG ID D06057
MeSH ID C487637
PubChem ID 9812715
TTD Drug ID D02IJB
NDC Product Code 65129-3104; 66220-315; 42513-0012
UNII 0701472ZG0
Synonyms telavancin | TD 6424 | TD6424 | TD-6424 | Vibativ | telavancin hydrochloride
Chemical Information
Molecular Formula C80H107Cl3N11O27P
CAS Registry Number 560130-42-9
SMILES CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)N C(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl) O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Chills08.01.09.001; 15.05.03.016--
Diarrhoea07.02.01.001--
Dysgeusia07.14.03.001; 17.02.07.003--
Nausea07.01.07.001--
Urine abnormality20.02.01.013---
Vomiting07.01.07.003--
Decreased appetite08.01.09.028; 14.03.01.005--
Acute kidney injury20.01.03.016--
The 1th Page    1    Total 1 Pages